Granules India Ltd.

NSE: GRANULES | BSE: 532482 | ISIN: INE101D01020 | Industry: Pharmaceuticals
| Mid-range Performer
533.9500 6.60 (1.25%)
NSE Jun 05, 2025 15:31 PM
Volume: 855.8K
 

533.95
1.25%
HDFC Securities
Maintain BUY with a revised TP of Rs 170 (16x Sep-19E EPS). Granules India (GRAN) reported another quarter of top-line growth (8% YoY), after a subdued FY17. Revenue was Rs 3.9bn, in-line with estimates. EBITDA was Rs 769mn (up ~4% YoY), implying a margin of 19.6%, ~190bps below estimates. An increase in employee costs (+8% QoQ) owing to hiring at the US subsidiary, led to the subdued margin performance. A higher tax rate and increasing finance costs (additional debt taken on during 2QFY18) led to PAT declining 1% YoY to Rs 403mn.
Granules India Ltd. has gained 17.20% in the last 1 Month
More from Granules India Ltd.
Recommended